{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T19:11:42Z","timestamp":1768417902201,"version":"3.49.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1093\/annonc\/mdy482","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T11:13:24Z","timestamp":1540466004000},"page":"151-152","source":"Crossref","is-referenced-by-count":8,"title":["Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting"],"prefix":"10.1016","volume":"30","author":[{"given":"H.T.","family":"van der Gali\u00ebn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hoogendoorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.E.","family":"Kibbelaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"van Meerten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.S.","family":"van Rijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1093\/annonc\/mdy482_bb0010","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1093\/annonc\/mdy203","article-title":"Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials","volume":"29","author":"Maurer","year":"2018","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1093\/annonc\/mdy482_bb0015","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3109\/10428194.2013.810737","article-title":"Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a population-based cohort study on treatment, toxicity and outcome","volume":"55","author":"Boslooper","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdy482_bb0020","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejca.2017.09.007","article-title":"Bridging the gap between the randomised clinical trial world and the real world by combination of population-based registry and electronic health record data: a case study in haemato-oncology","volume":"86","author":"Kibbelaar","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdy482_bb0025","first-page":"214769","article-title":"Outcome of a 10-year population-based cohort of diffuse large b-cell lymphoma patients in the first-line, refractory and relapsed setting: \u2018Real-world\u2019 data identify subgroups in need of new therapies [abstract]","author":"Van der Galien","year":"2018","journal-title":"23rd Congress of European Hematology Association"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419309925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419309925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/30\/1\/151\/27511301\/mdy482.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T08:45:45Z","timestamp":1624697145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419309925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":4,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0923753419309925"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdy482","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}